Discover 281 paid clinical trials in West Virginia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
West Virginia currently offers numerous opportunities for healthy volunteers and those with specific medical conditions to engage in paid research studies. Key locations such as Charleston, Huntington, and Morgantown are enrolling participants, granting access to emerging treatments and expert care.
Filter
1
Filter results
Results: 281
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: Boston MA, New Haven CT, Stony Brook NY, Lake Sucess NY,
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 0+
Code: NCT01351545
Recruiting
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Boston MA, Stony Brook NY, Mineola NY, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06380751
Phase3, Recruiting
Application Of Autologous Blood Products During Modified Radical Mastectomy
for
Mastectomy
Location: Huntington WV
Sponsor: Marshall University
Sex: All
Age: 18+
Code: NCT00802477
Phase3, Recruiting
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
Location: New York NY, Baltimore MD, Chapel Hill NC,
Sponsor: Beat AML, LLC
Sex: All
Age: 18+
Code: NCT03013998
Phase2, Phase3, Recruiting
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
for
Prediabetic State, Atherosclerosis, Metformin
Location: Boston MA, West Haven CT, New York NY, Baltimore MD,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT02915198
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: Boston MA, Providence RI, Norwalk CT, New York NY,
Sponsor: Fore Biotherapeutics
Sex: All
Age: 8+
Code: NCT05503797
Phase2, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: North Dartmouth MA, Quebec, Toms River NJ,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06883305
Phase3, Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for
Obstructive Hypertrophic Cardiomyopathy
Location: Boston MA, Roslyn NY, Valhalla NY, New York NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05489705
Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for
End Stage Kidney Disease
Location: Halifax, Portsmouth NH, Boston MA, East Providence RI,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT05485961
Phase2, Phase3, Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
for
Hypoxic-Ischemic Encephalopathy
Location: Boston MA, Durham NC, Miami FL, Morgantown WV,
Sponsor: ReAlta Life Sciences, Inc.
Sex: All
Age: 0
Code: NCT05778188
Phase2, Recruiting
Abatacept in Immune Checkpoint Inhibitor Myocarditis
for
Myocarditis Acute, Cancer
Location: Portland ME, Boston MA, New York NY, New Brunswick NJ,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT05335928
Phase3, Recruiting
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
for
Cardiotoxicity, HER2/Neu Positive,
Location: Winchester MA, Burlington MA, White Plains NY, Nyack NY,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT03418961
Phase3, Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Scarborough ME, South Weymouth MA, Boston MA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase3, Recruiting
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
for
Degenerative Disc Disease, Disc Degeneration,
Location: Shrewsbury NJ, New York NY, New Bern NC, Gainesville FL,
Sponsor: VIVEX Biologics, Inc.
Sex: All
Age: 22 - 70+
Code: NCT06778447
Recruiting
Effectiveness of Aurix Therapy in Venous Leg Ulcers
for
Venous Leg Ulcers
Location: Boston MA, Bristol CT, Middletown NY, Harris NY,
Sponsor: Nuo Therapeutics
Sex: All
Age: 18+
Code: NCT02352454
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer